BioBeat19: Accelerating Cell and Gene Therapy
BioBeat is an annual summit that connects entrepreneurs with the leaders in biotech. GSK and Stevenage Bioscience Catalyst are delighted to host BioBeat19 at the Stevenage campus from 13:00 – 18.00 on Tuesday, 19th November 2019.
The focus this year is on “Accelerating Cell and Gene Therapy” and GSK’s CEO Emma Walmsley will be the keynote speaker. The summit will explore the journey from science to patients and what value means for different people and organisations.
This half day event is open to all scientists, investors and entrepreneurs. Leading women will discuss opportunities and catalyse ideas with the audience.
Register today: http://www.biobeat19.org